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Although proximal gastrectomy (PG) is a recognized surgical procedure for early proximal
gastric cancer, total gastrectomy (TG) is sometimes selected due to concern about severe
gastroesophageal reflux. Esophagogastrostomy by the double-flap technique (DFT) is an
anti-reflux reconstruction after PG, and its short-term effectiveness has been reported. How-
ever, little is known about the long-term effects on nutritional status and quality of life (QOL).
Methods
Gastric cancer patients who underwent laparoscopy-assisted PG (LAPG) with DFT or lapa-
roscopy-assisted TG (LATG) between April 2011 and March 2014 were retrospectively ana-
lyzed. Body weight (BW), body mass index (BMI), and prognostic nutritional index (PNI)
were reviewed to assess nutritional status, and the Postgastrectomy Syndrome Assess-
ment Scale (PGSAS)-45 was used to assess QOL.
Results
A total of 36 patients (LATG: 17, LAPG: 19) were enrolled. Four of 17 LATG patients (24%)
were diagnosed with Stage�II after surgery, and half received S-1 adjuvant chemotherapy.
BW and PNI were better maintained in LAPG than in LATG patients until 1-year follow-up.
Seven of 16 LATG patients (44%) were categorized as “underweight (BMI<18.5 kg/m2)” at
1-year follow-up, compared to three of 18 LAPG patients (17%; p = 0.0836). The PGSAS-45
showed no significant difference in all QOL categories except for decreased BW (p =
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0.0132). Multivariate analysis showed that LATG was the only potential risk factor for severe
BW loss (odds ratio: 3.03, p = 0.0722).
Conclusions
LAPG with DFT was superior to LATG in postoperative nutritional maintenance, and can be
the first option for early proximal gastric cancer.
Introduction
Proximal gastrectomy (PG) is described in the Japanese gastric cancer treatment guideline as a
surgical procedure that can be considered for proximal tumors where more than half of the dis-
tal stomach can be preserved [1]. Though PG is preferable in terms of organ preservation and
function preservation, no standard reconstruction method after PG has yet been established,
mainly due to the problem of gastroesophageal reflux after surgery [2]. Esophagogastrostomy
(EG) with no additional anti-reflux procedure often causes severe reflux esophagitis, and even
alternative procedures, such as jejunal interposition (JI), jejunal pouch interposition (JPI), and a
double-tract (DT), do not resolve this problem satisfactorily. Unsuccessful reconstruction after
PG causes substantial decline in quality of life (QOL) after surgery [3], and for this reason, total
gastrectomy (TG) is sometimes selected as the first option at the expense of stomach preserva-
tion, although the prognosis after PG is reportedly comparable to that after TG [4, 5].
Our first-choice reconstruction method for proximal gastric cancer is PG with the double-
flap technique (DFT) reconstruction. DFT reconstruction, also known as the Kamikawa proce-
dure, is an anti-reflux EG after PG, first reported by Kamikawa et al in 1998, in which the distal
esophagus and the anastomosis are embedded into the submucosal space of the gastric rem-
nant and covered by the seromuscular double-flap [6, 7]. While DFT reconstruction has been
reported to show acceptable short-term outcomes in preventing reflux esophagitis after sur-
gery in a multicenter, retrospective study [8], there is little evidence of the long-term outcomes,
including patients’ QOL.
In the present study, the feasibility of laparoscopy-assisted PG (LAPG) with DFT recon-
struction was compared with that of laparoscopy-assisted TG (LATG) in terms of short-term
and long-term effects on body weight (BW) and QOL after surgery. This study will help estab-
lish a standard surgical procedure for early proximal gastric cancer.
Methods
Patients
The medical records of patients with gastric cancer who underwent LAPG with D1+ lymph
node dissection followed by DFT reconstruction or who underwent LATG with D1+ lymph
node dissection followed by Roux-en-Y reconstruction between April 2011 and March 2014 at
Okayama University Hospital were reviewed. This study was reviewed and approved by the
institutional review board (IRB) of Okayama University Hospital (#1505–022). The IRB
waived the requirement to obtain informed consent for this study.
Surgical procedures of LATG and LAPG
In both LATG and LAPG, gastrectomy and lymph node dissection were performed laparosco-
pically in a conventional 5-port setting, and reconstruction was performed under direct vision
through a small incision placed in the epigastrium. Esophago-jejunal anastomosis and jejuno-
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jejunal anastomosis in LATG were conducted using a circular stapler and a linear stapler,
respectively. DFT reconstruction was conducted by a complete hand-sewn suturing process, as
previously reported [6].
Clinical data
Patients’ characteristics included age, sex, height, BW, body mass index (BMI), preoperative co-
morbidities, American Society of Anesthesiologists physical status (ASA-PS) classification, vital
capacity (VC), forced expiratory volume 1.0 (FEV1.0), prognostic nutritional index (PNI) and
presence or absence of sarcopenia. Histological findings such as histological type, pathological
depth of tumor (pT), pathological lymph node metastasis (pN), and pathological stage (pStage)
were described according to the 3rd English edition of the Japanese Classification of Gastric Carci-
noma [9]. Surgical outcomes included operation time, blood loss, length of skin incision, presence
or absence of concurrent cholecystectomy, postoperative complications classified according to the
Clavien-Dindo classification, highest body temperature (BT) after surgery, duration of BT
�37.5˚C, the number of days until the first flatus after surgery, and the length of hospital stay after
surgery. BW was recorded at 1-month, 6-month, and 1-year follow-ups, and PNI was recorded at
6-month and 1-year follow-ups as well. At 1-year follow-up, reflux esophagitis was evaluated by
endoscopic examination and classified according to the Los Angeles (LA) classification [10].
QOL survey
At approximately 3 years after surgery, a QOL survey was carried out by mail using the ques-
tionnaire of the Postgastrectomy Syndrome Assessment Scale (PGSAS)-45, which consists of a
total of 45 questions [11, 12]. Based on this questionnaire, the total symptom score and the 7
symptom subscales (SS) for esophageal reflux, abdominal pain, meal-related distress, indiges-
tion, diarrhea, constipation, and dumping were calculated. In addition, decreased BW,
ingested amount of food per meal, need for additional meals, quality of ingestion, ability to
work, dissatisfaction with symptoms, dissatisfaction with meals, dissatisfaction with working,
dissatisfaction with daily life, physical component summary, and mental component summary
were also assessed. PGSAS-45 was proved to be a valid and reliable questionnaire for assess-
ment of living status and QOL in postgastrectomy patients in a previous study [11].
Statistical analysis
Statistical analysis was conducted using JMP software (SAS Institute, Cary, NC, USA). Stu-
dent’s t-test was used to assess the continuous variables of age, BW, BMI, VC, FEV1.0, and
PNI. The Wilcoxon signed-rank test was used for the other continuous variables of operation
time, blood loss, length of skin incision, highest BT, duration of BT�37.5˚C, the number of
days until the first flatus after surgery, and the length of hospital stay after surgery. Pearson’s
χ2 test was used for the categorical variables of sex, presence of preoperative co-morbidities,
ASA-PS, histological type, pT, pN, pStage, concurrent cholecystectomy, postoperative compli-
cations, and BMI <18.5 kg/m2. QOL was also compared by the Wilcoxon signed-rank test.
Overall survival and recurrence-free survival curves were evaluated using the Kaplan-Meier
method. A p value <0.05 was considered significant.
Results
Patients’ characteristics
A total of 36 patients were enrolled, 17 patients who underwent LATG and 19 patients who
underwent LAPG (Fig 1). In the patients’ characteristics and histological findings (Table 1),
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there were no significant differences between LATG and LAPG except for histological type
and pStage. The proportion of undifferentiated type was significantly higher in LATG (44%)
than in LAPG (5%) (p = 0.0069). All 19 patients who underwent LAPG were diagnosed with
pStage I after surgery, whereas four of 17 patients (24%) who underwent LATG were diag-
nosed with pStage II or higher after surgery, although all 17 patients were diagnosed with clini-
cal T1 and N0 before surgery, and 2 of the 4 patients received adjuvant chemotherapy with S-1
after surgery according to the Japanese gastric cancer treatment guidelines 2010 (ver.3) [1].
The Kaplan-Meier survival analysis (median follow-up period, 4.2 years) showed that there
were no significant differences between LATG and LAPG in overall survival (p = 0.5229) and
recurrence-free survival (p = 0.9202) (Fig 2).
Surgical outcomes
In surgical outcomes (Table 2), operation time was not significantly different between LATG
(306 min) and LAPG (280 min) (p = 0.6804), whereas blood loss was significantly higher in
LAPG (210 mL) than in LATG (70 mL) (p = 0.0106). The skin incision placed in the epigas-
trium for reconstruction was significantly longer in LAPG (8 cm) than in LATG (7 cm)
(p = 0.0349), which may have been influenced by complexity of reconstruction procedure.
There was no significant difference in the incidence of postoperative complications
(p = 0.9060). In detail, the incidence of postoperative complications (CD any grade) in LATG
was 12% (two of 17 patients) including an anastomotic leakage (5%), while that in LAPG was
11% (two of 19 patients), including an anastomotic stricture (5%). In the postoperative
courses, there were no significant differences except for the number of days until the first flatus
after surgery, which was significantly higher in LATG (2 days) than in LAPG (1 day)
(p = 0.0168). This meant earlier recovery of bowel function in LAPG and may have led to
Fig 1. CONSORT diagram.
https://doi.org/10.1371/journal.pone.0242223.g001
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shorter hospital stay in LAPG (12 days) than in LATG (13 days) although difference was not
statistically significant (p = 0.1241).
One-year follow-up
Overall, 16 patients who underwent LATG and 18 patients who underwent LAPG were moni-
tored for at least until one year after surgery (Fig 1). BW change at 1, 6, and 12 months after
surgery (LATG vs LAPG) was -10.4% vs -8.2%, -17.1% vs -10.4%, and -17.8% vs -9.8%, respec-
tively; BW loss was significantly smaller in LAPG at every time point (Fig 3A). The same
applied to the change in PNI. PNI change at 6 and 12 months after surgery (LATG vs LAPG)
Table 1. Patients’ characteristics and histological findings.
LATG (n = 17) LAPG (n = 19) p value
Age, y
Mean ± SD 68.9 ± 12.1 71.2 ± 8.0 0.5063
Sex
Male 11 (65%) 16 (84%) 0.1773
Female 6 (35%) 3 (16%)
BMI, kg/m2
Mean ± SD 23.6 ± 3.3 23.5 ± 3.5 0.9363
Preoperative co-morbidities
Yes 11 (65%) 15 (79%) 0.3409
ASA-PS
1 3 (18%) 2 (11%) 0.8266
2 9 (53%) 11 (58%)
�3 5 (29%) 6 (32%)
VC, %
Mean ± SD 105.4 ± 18.2 99.5 ± 18.2 0.3390
FEV1.0, %
Mean ± SD 73.1 ± 9.3 73.1 ± 10.9 0.9925
PNI
Mean ± SD 51.3 ± 6.0 51.1 ± 5.6 0.9049
Sarcopenia
Yes 3 (20%) 4 (24%) 0.8096
Histological type
Differentiated 9 (56%) 18 (95%) 0.0069
Undifferentiated 7 (44%) 1 (5%)
Pathological T status (pT)
1 14 (82%) 17 (89%) 0.5374
�2 3 (18%) 2 (11%)
Pathological N status (pN)
0 14 (82%) 18 (95%) 0.2379
�1 3 (18%) 1 (5%)
Pathological Stage (pStage)
IA 13 (76%) 16 (84%) 0.0270
IB 0 (0%) 3 (16%)
�II 4 (24%) 0 (0%)
BMI, body mass index; VC, vital capacity; FEV1.0, forced expiratory volume 1.0; PNI, prognostic nutritional index; SD, standard deviation.
https://doi.org/10.1371/journal.pone.0242223.t001
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was -7.3% vs +1.4% and -9.8% vs -3.7%, respectively; PNI was significantly higher in LAPG at
every time point (Fig 3B). When BMI<18.5 kg/m2 was defined as “underweight”, seven of 16
LATG patients (44%) and three of 18 LAPG patients (17%) were categorized as “underweight”
at 1-year follow-up (p = 0.0836), though no patient in both procedures was categorized as
“underweight” before surgery (Fig 3C). Endoscopic examination at 1-year follow-up showed
that no LAPG patient had reflux esophagitis, whereas one LATG patient had reflux esophagitis
(LA grade C) (Fig 3D).
Fig 2. Kaplan-Meier survival analysis. a. Overall survival. b. Recurrence-free survival.
https://doi.org/10.1371/journal.pone.0242223.g002
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Postoperative QOL assessment with the PGSAS-45
Twenty-nine of 36 patients responded to the QOL survey by mail (collection rate, 81%),
including 13 of 17 LATG patients and 16 of 19 LAPG patients in, and the median time after
surgery of these patients at the time of this QOL survey was 3.1 years (Fig 1). There were no
significant differences in all categories between LATG and LAPG patients except for decreased
BW (p = 0.0132), which was 15.1% in LATG patients and 9.6% in LAPG patients (Table 3).
The esophageal reflux SS of LAPG was 1.3, which was as good as the 1.5 of LATG. When BW
loss�15% was defined as “severe BW loss”, univariate and multivariate analyses showed that
LATG was a potential risk factor for “severe BW loss” (odds ratio: 3.03, p = 0.0722) (Table 4).
Discussion
In the present study, the advantages of LAPG with DFT over LATG were evaluated in terms of
short-term and long-term nutritional maintenance. BW and PNI were actually better main-
tained after LAPG with DFT than after LATG until 1-year follow up, which was consistent
with many previous reports. Sugiyama et al reported that laparoscopic PG (LPG) with DT
reconstruction maintained BW and skeletal muscle better than laparoscopic TG (LTG) at 1
year after surgery [13], and Kosuga et al reported that nutritional status, such as changes in
BW and blood chemistries including hemoglobin, serum albumin, and total lymphocyte
count, was consistently better in LPG with EG than LTG at 6 months and 1 and 2 years after
surgery [14]. BMI is a simple value calculated from weight and height, and it is a convenient
Table 2. Surgical outcomes.
LATG (n = 17) LAPG (n = 19) p value
Operation time, min
Median (IQR) 306 (256.5–371.5) 280 (264–345) 0.6804
Blood loss, mL
Median (IQR) 70 (40–117.5) 210 (90–285) 0.0106
Skin incision, cm
Median (IQR) 7 (6–8) 8 (7–10) 0.0349
Concurrent cholecystectomy
Yes 2 (12%) 2 (11%) 0.9060
Postoperative complications
Any Gradea 2 (12%) 2 (11%) 0.9060
Anastomotic leakage 1 (5%) 0 (0%)
Anastomotic stricture 0 (0%) 1 (5%)
Pneumonia 0 (0%) 1 (5%)
Urinary tract infection 1 (5%) 0 (0%)
Highest BT, oC
Median (IQR) 38.0 (37.5–38.65) 37.9 (37.5–38.2) 0.6913
Duration of BT�37.5 oC
Median (IQR) 1 (0.5–3) 1 (0–2) 0.3554
First flatus, POD
Median (IQR) 2 (2–3) 1 (1–2) 0.0168
Hospital stay, days
Median (IQR) 13 (11.5–15) 12 (11–14) 0.1241
BT, body temperature; POD, postoperative day; IQR, interquartile range.
a according to the Clavien-Dindo classification.
https://doi.org/10.1371/journal.pone.0242223.t002
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measure representing nutritional status. BMI <18.5 kg/m2 is defined as “underweight” in the
World Health Organization (WHO) criteria, and being “underweight” is in general associated
with a variety of health risks. In gastric cancer as well, “underweight” patients were reported to
have the worst overall survival and disease-specific survival among six categories (“under-
weight”, “normal-weight”, “overweight”, “mildly obese”, “moderately obese”, and “severely
obese”) divided according to BMI [15]. In the present study, seven of 16 patients (44%) were
“underweight” 1 year after LATG, though no patient was “underweight” before surgery. Two
patients died after LATG in the present study, both of whom were “underweight” 1 year after
surgery, and the causes of death were gastric cancer death and multiple organ failure. In con-
trast, only three of 18 patients (17%) were “underweight” 1 year after LAPG, but one of 4
patients who died after LAPG was “underweight” 1 year after surgery, and the cause of death
was pneumonitis. Based on these results, severe BW loss, especially to BMI<18.5 kg/m2, is
critical, and, therefore, PG, which can maintain BW better than TG, will be recommended for
early proximal gastric cancer from the standpoint of nutritional maintenance and health risks.
However, to select PG as a standard procedure for early proximal gastric cancer, a recon-
struction method that can effectively maintain the patients’ postoperative QOL is definitely
Fig 3. Follow-up to one year after surgery. a. Change in body weight. �, p<0.05. b. Change in PNI. �, p<0.05. c. Change in BMI. BMI� 18.5 kg/m2 is defined as
“underweight”. POY, postoperative year. d. Incidence of reflux esophagitis.
https://doi.org/10.1371/journal.pone.0242223.g003
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necessary. DFT, one of the EGs with an anti-reflux procedure, has recently been becoming
increasingly commonly performed in Japan based on its capability of effectively preventing
Table 3. Postoperative QOL assessment with PGSAS-45.
LATG (n = 13) LAPG (n = 16) p value
Median IQR Median IQR
Symptoms
Esophageal reflux 1.5 (1.1–2.5) 1.3 (1.0–2.4) 0.3531
Abdominal pain 1.3 (1.0–1.7) 1.7 (1.0–2.2) 0.5112
Meal-related distress 2.7 (2.0–4.0) 2.3 (1.7–2.7) 0.2509
Indigestion 2.0 (1.8–2.6) 1.9 (1.0–2.7) 0.6419
Diarrhea 2.7 (1.5–3.7) 2.0 (1.2–3.3) 0.5511
Constipation 2.0 (1.3–2.8) 2.5 (1.8–3.3) 0.2607
Dumping 2.0 (1.0–2.7) 1.0 (1.0–2.1) 0.1999
Total symptom 1.9 (1.7–2.8) 1.9 (1.5–2.4) 0.6930
Living status
Decrease in body weight (%) 15.1 (14.5–24.6) 9.6 (5.0–14.4) 0.0132
Ingested amount of food per meal 6.0 (5.0–8.0) 6.5 (5.0–8.0) 0.5314
Necessity for additional meals 2.0 (1.5–2.5) 2.0 (1.0–2.0) 0.3275
Quality of ingestion 4.0 (3.3–4.7) 3.8 (3.0–4.9) 0.7557
Ability for work 2.0 (1.5–2.5) 2.0 (1.0–3.8) 0.6313
QOL
Dissatisfaction with symptoms 1.0 (1.0–2.0) 1.0 (1.0–1.8) 0.5368
Dissatisfaction at the meals 3.0 (1.0–3.0) 3.0 (1.0–3.0) 0.6005
Dissatisfaction at working 1.0 (1.0–2.0) 1.5 (1.0–3.0) 0.4388
Dissatisfaction for daily life 2.0 (1.0–2.5) 1.5 (1.0–2.8) 0.9283
Physical component summary 52.2 (49.5–52.9) 47.9 (41.4–54.3) 0.1604
Mental component summary 51.6 (44.5–55.2) 53.2 (45.6–54.9) 0.9650
https://doi.org/10.1371/journal.pone.0242223.t003
Table 4. Univariate and multivariate analyses of risk factors for severe body weight loss.
Univariate Multivariate
p value OR p value
Background Age (�80 y) 0.3414
Sex (Male) 0.1552





Pathological Stage (pStage�II) 0.5714
Operation Operation procedure (LATG) 0.0462 3.03 0.0722
Operation time (�360 min) 0.7064
Blood loss (�300 mL) 0.6569
Postoperative complications 0.4911
Clavien-Dindo (�II) 1.0000
Postoperative chemotherapy (+) 0.6402
BMI, body mass index; PNI, prognostic nutritional index; CI, confidence interval; OR, odds ratio.
https://doi.org/10.1371/journal.pone.0242223.t004
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gastroesophageal reflux after surgery, leading to a large decline in postoperative QOL [16]. In
the present study, reflux esophagitis was not observed in any patients on endoscopic examina-
tion at 1-year follow-up after LAPG with DFT, whereas the incidence of reflux esophagitis (LA
grade B or higher) after DFT investigated in a previous multicenter retrospective study was
6.0%, which was considered acceptable [8]. The PGSAS-45 questionnaire, in which the severity
of gastroesophageal reflux is assessed by the esophageal reflux SS, was used for the QOL survey
in the present study. The range of this scale is 1.0 to 5.0, and a smaller value means less symp-
toms. In the present study, the esophageal reflux SS of LAPG was 1.3, which was considered
relatively good and comparable to that of LATG, in which esophageal reflux is fundamentally
unlikely to happen. When the present data of the esophageal reflux SS of LAPG were compared
with the previous national multi-institutional data of this scale of the PGSAS-45 after PG [17],
in which 115 cases of EG, 34 cases of JI, and 44 cases of JPI were included, by using the PGSAS
Statistics Kit available on the web, the esophageal reflux SS of the present study (mean: 1.6,
standard deviation [SD]: 0.8) was better than that of the national data (mean: 2.0, SD: 1.0)
(p = 0.063, Cohen’s d = 0.41) [18], which may show that DFT has some advantage over a vari-
ety of reconstruction methods after PG.
While the present study produced some interesting outcomes, it does have several limita-
tions. First, this was a retrospective, single-center study with a limited number of cases. Sec-
ond, four LATG patients were diagnosed with advanced stage gastric cancer, and two of them
received adjuvant chemotherapy with S-1 for a year after surgery, which may have affected
postoperative nutritional status. Third, nutritional status was evaluated only by BW and PNI,
and other major nutritional indices, such as the Glasgow Prognostic Score (GPS), the neutro-
phil/lymphocyte ratio (NLR), and Controlling Nutritional Status (CONUT score), were not
assessed in this study. Then, considering the surgical outcomes, the reason why blood loss was
significantly higher in LAPG than in LATG was actually hard to explain, but one possibility
might be that gastric fluid overflowing during the DFT procedure was counted as blood loss.
Although a comparison of DFT with other EGs or other types of reconstruction methods
such as DT was the most intriguing topic in the evaluation of appropriate reconstruction
methods after PG, the present study demonstrated that LAPG with DFT was superior at least
to LATG in terms of short-term and long-term nutritional maintenance after surgery, without
decreasing QOL. Focusing on BW loss after surgery, this study showed that TG was associated
with a higher risk of “underweight” (BMI <18.5 kg/m2) after surgery, which leads to overall
health risks irrespective of cancer, and was the only potential risk factor for severe BW loss
(>15%) on univariate and multivariate analyses. In conclusion, LAPG with DFT reconstruc-
tion can be the first option for early gastric cancer located in the proximal stomach from a
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